US FDA approves single-shot Johnson & Johnson Covid-19 vaccine

Share

Tweet

Share

Share

Email

Comments

The US Food and Drug Administration (FDA) has formally approved the single-shot Johnson & Johnson coronavirus vaccine. This is the third vaccine to be authorised in the country.

The vaccine is set to be a cost-effective alternative to the Pfizer and Moderna vaccines and can be stored in a refrigerator instead of a freezer.

The first doses could be available to the US public as early as next week. The UK, EU and Canada have also ordered doses, and 500 million doses have also been ordered through the Covax scheme to supply poorer nations.

President Joe Biden hailed it as an encouraging development for Americans but warned that the fight is far from over.